Shanghai Haohai Biological Technology Statistics

Total Valuation

Shanghai Haohai Biological Technology has a market cap or net worth of HKD 12.88 billion. The enterprise value is 10.80 billion.

Market Cap	12.88B
Enterprise Value	10.80B

Important Dates

The next estimated earnings date is Saturday, March 22, 2025.

Earnings Date	Mar 22, 2025
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Shanghai Haohai Biological Technology has 230.28 million shares outstanding. The number of shares has decreased by -1.78% in one year.

Current Share Class	n/a
Shares Outstanding	230.28M
Shares Change (YoY)	-1.78%
Shares Change (QoQ)	+1.75%
Owned by Insiders (%)	61.49%
Owned by Institutions (%)	10.12%
Float	88.69M

Valuation Ratios

The trailing PE ratio is 17.67 and the forward PE ratio is 11.73.

PE Ratio	17.67
Forward PE	11.73
PS Ratio	2.77
PB Ratio	1.34
P/TBV Ratio	2.57
P/FCF Ratio	16.40
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.56, with an EV/FCF ratio of 30.04.

EV / Earnings	22.66
EV / Sales	3.55
EV / EBITDA	16.56
EV / EBIT	24.08
EV / FCF	30.04

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.07.

Current Ratio	4.30
Quick Ratio	3.57
Debt / Equity	0.07
Debt / EBITDA	0.77
Debt / FCF	1.39
Interest Coverage	34.56

Financial Efficiency

Return on equity (ROE) is 6.63% and return on invested capital (ROIC) is 3.94%.

Return on Equity (ROE)	6.63%
Return on Assets (ROA)	3.53%
Return on Capital (ROIC)	3.94%
Revenue Per Employee	1.41M
Profits Per Employee	220,811
Employee Count	2,158
Asset Turnover	0.38
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.37% in the last 52 weeks. The beta is 0.74, so Shanghai Haohai Biological Technology's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-6.37%
50-Day Moving Average	28.74
200-Day Moving Average	30.08
Relative Strength Index (RSI)	31.50
Average Volume (20 Days)	202,520

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Haohai Biological Technology had revenue of HKD 3.04 billion and earned 476.51 million in profits. Earnings per share was 1.45.

Revenue	3.04B
Gross Profit	2.10B
Operating Income	448.35M
Pretax Income	559.74M
Net Income	476.51M
EBITDA	627.63M
EBIT	448.35M
Earnings Per Share (EPS)	1.45

Full Income Statement

Balance Sheet

The company has 2.98 billion in cash and 500.99 million in debt, giving a net cash position of 2.48 billion or 10.77 per share.

Cash & Cash Equivalents	2.98B
Total Debt	500.99M
Net Cash	2.48B
Net Cash Per Share	10.77
Equity (Book Value)	6.68B
Book Value Per Share	19.13
Working Capital	3.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 746.01 million and capital expenditures -386.54 million, giving a free cash flow of 359.47 million.

Operating Cash Flow	746.01M
Capital Expenditures	-386.54M
Free Cash Flow	359.47M
FCF Per Share	1.56

Full Cash Flow Statement

Margins

Gross margin is 69.10%, with operating and profit margins of 14.74% and 15.66%.

Gross Margin	69.10%
Operating Margin	14.74%
Pretax Margin	18.40%
Profit Margin	15.66%
EBITDA Margin	20.63%
EBIT Margin	14.74%
FCF Margin	11.81%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 3.32%.

Dividend Per Share	0.85
Dividend Yield	3.32%
Dividend Growth (YoY)	387.90%
Years of Dividend Growth	1
Payout Ratio	47.31%
Buyback Yield	1.78%
Shareholder Yield	5.10%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 6, 2024. It was a forward split with a ratio of 1.4.

Last Split Date	Jun 6, 2024
Split Type	Forward
Split Ratio	1.4

Scores

Shanghai Haohai Biological Technology has an Altman Z-Score of 8.66.

Altman Z-Score	8.66
Piotroski F-Score	n/a